Salt Lake City, UT, Aug. 14, 2019 (GLOBE NEWSWIRE) — Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today the filing of its … Continue reading Co-Diagnostics, Inc Reports Quarter on Quarter Sales Growth for Q2 2019